AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2024
Sep 18, 2024
29745_dirs_2024-09-18_33bdcf66-397d-4a54-a5a4-a6a4ea605c62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-09-09
Reporting Person: Montarce Lucas (EVP & CFO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10467 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $ | 2027-02-16 | Common Stock (371) | Direct | |
| Restricted Stock Unit | $ | 2024-11-01 | Common Stock (1074) | Direct | |
| Restricted Stock Unit | $ | 2026-02-16 | Common Stock (368) | Direct | |
| Restricted Stock Unit | $ | 2026-11-01 | Common Stock (1610) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29